Published in Menopause on June 01, 2013
Estradiol and cognitive function: past, present and future. Horm Behav (2014) 1.13
Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol (2013) 1.10
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse. Physiol Rev (2015) 0.95
Effect of Ovarian Hormone Therapy on Cognition in the Aged Female Rhesus Macaque. J Neurosci (2016) 0.91
Functional and molecular neuroimaging of menopause and hormone replacement therapy. Front Neurosci (2014) 0.86
Prescribing menopausal hormone therapy: an evidence-based approach. Int J Womens Health (2014) 0.81
Effects of hormone therapy on cognition and mood. Fertil Steril (2014) 0.81
Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Neurology (2016) 0.80
Sex steroid hormones matter for learning and memory: estrogenic regulation of hippocampal function in male and female rodents. Learn Mem (2015) 0.80
Testing the Critical Window Hypothesis of Timing and Duration of Estradiol Treatment on Hypothalamic Gene Networks in Reproductively Mature and Aging Female Rats. Endocrinology (2015) 0.79
Re-Opening the Critical Window for Estrogen Therapy. J Neurosci (2015) 0.79
Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons. Horm Behav (2015) 0.77
The complexities of hormonal influences and risk of Parkinson's disease. Mov Disord (2014) 0.77
Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. J Alzheimers Dis (2016) 0.77
Postmenopausal hormone therapy and cognition. Horm Behav (2015) 0.77
Long-term consequences of estrogens administered in midlife on female cognitive aging. Horm Behav (2015) 0.77
Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. Neurology (2015) 0.77
An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk. PLoS One (2013) 0.77
Effects of Hormone Therapy on Intraocular Pressure: The Women's Health Initiative-Sight Exam Study. Am J Ophthalmol (2016) 0.76
Trajectories and phenotypes with estrogen exposures across the lifespan: What does Goldilocks have to do with it? Horm Behav (2015) 0.76
Sex and the development of Alzheimer's disease. J Neurosci Res (2017) 0.76
Is timing everything? New insights into why the effect of estrogen therapy on memory might be age dependent. Endocrinology (2013) 0.76
Actions and interactions of estradiol and glucocorticoids in cognition and the brain: Implications for aging women. Neurosci Biobehav Rev (2015) 0.76
Modeling menopause: The utility of rodents in translational behavioral endocrinology research. Maturitas (2016) 0.76
Aging and Loss of Circulating 17β-Estradiol Alters the Alternative Splicing of ERβ in the Female Rat Brain. Endocrinology (2015) 0.76
Effects of Hormone Therapy on Brain Volumes Changes of Postmenopausal Women Revealed by Optimally-Discriminative Voxel-Based Morphometry. PLoS One (2016) 0.76
GnRH neurons of young and aged female rhesus monkeys co-express GPER but are unaffected by long-term hormone replacement. Neuroendocrinology (2014) 0.76
Age and Long-Term Hormone Treatment Effects on the Ultrastructural Morphology of the Median Eminence of Female Rhesus Macaques. Neuroendocrinology (2015) 0.75
Endogenous sex hormones and cognitive function in older women. Alzheimers Dement (2016) 0.75
Progestogens' effects and mechanisms for object recognition memory across the lifespan. Behav Brain Res (2015) 0.75
Characterization of ovarian aging and reproductive senescence in vervet monkeys (Chlorocebus aethiops sabaeus). Comp Med (2014) 0.75
Distinct cognitive effects of estrogen and progesterone in menopausal women. Psychoneuroendocrinology (2015) 0.75
Why estrogens matter for behavior and brain health. Neurosci Biobehav Rev (2016) 0.75
Age-dependent regulation of obesity and Alzheimer-related outcomes by hormone therapy in female 3xTg-AD mice. PLoS One (2017) 0.75
Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol (2003) 14.87
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA (2003) 5.26
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
Postmenopausal hormone replacement therapy: scientific review. JAMA (2002) 4.63
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol (2005) 4.49
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA (2011) 3.85
Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol (2007) 2.77
Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology (2005) 2.45
Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology (2009) 2.45
The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol (1995) 2.42
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med (2002) 2.41
Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci (2003) 2.40
Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA (2001) 2.32
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (1997) 2.30
Cognition in perimenopause: the effect of transition stage. Menopause (2013) 2.26
Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology (2005) 2.24
Alzheimer's disease: a study of epidemiological aspects. Ann Neurol (1984) 2.17
Hormone therapy and risk of Alzheimer disease: a critical time. JAMA (2002) 2.16
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA (1998) 2.14
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology (1992) 2.05
Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab (2006) 2.03
Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02
Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology (1988) 1.99
Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause (2006) 1.98
A case-control study of Alzheimer's disease in Australia. Neurology (1990) 1.98
Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology (2012) 1.96
Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology (2000) 1.85
Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med (2006) 1.76
Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause (2007) 1.76
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA (1999) 1.73
Early menopausal hormone use influences brain regions used for visual working memory. Menopause (2010) 1.67
Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry (2005) 1.62
Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord (2009) 1.58
Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med (1996) 1.57
Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology (2009) 1.53
The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials (2004) 1.52
Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol (1994) 1.50
Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology (1986) 1.48
Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb Cortex (2004) 1.48
Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry (2005) 1.45
Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol (2010) 1.44
Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging (2000) 1.43
Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology (2007) 1.43
Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol (1994) 1.41
The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience (2000) 1.41
Estrogen + progestin therapy and cognition: a randomized placebo-controlled double-blind study. J Obstet Gynaecol Res (2010) 1.40
Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Neurology (2009) 1.32
Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology (1999) 1.31
Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology (2000) 1.29
Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav (1998) 1.27
Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci (2005) 1.27
Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol Aging (2006) 1.27
A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging (2005) 1.24
Developmental sex differences in verbal learning. Neuropsychology (1997) 1.16
Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. J Clin Endocrinol Metab (2009) 1.13
Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging (2003) 1.11
A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use. Ann N Y Acad Sci (2005) 1.10
Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol (2006) 1.10
Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res (2010) 1.08
Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci (2009) 1.05
Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future. Menopause (2013) 1.04
Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study. Neurology (2009) 1.03
Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas (2001) 1.02
Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause (2003) 1.01
Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology (1998) 1.00
Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies. Semin Reprod Med (2009) 1.00
Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women. Neurology (2004) 0.99
Effects of botanicals and combined hormone therapy on cognition in postmenopausal women. Menopause (2009) 0.94
Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol (2001) 0.93
A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women. Psychoneuroendocrinology (2009) 0.92
A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics. Neurology (1999) 0.92
Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology (1998) 0.92
Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung (2001) 0.92
Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology (2004) 0.92
The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women. J Am Geriatr Soc (2007) 0.91
A case-control study of Alzheimer's disease. Ann Neurol (1990) 0.91
Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology (1999) 0.90
Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology (2007) 0.89
Reversibility of the effects of acute ovarian hormone suppression on verbal memory and prefrontal function in pre-menopausal women. Psychoneuroendocrinology (2008) 0.89
Estradiol or estradiol/progesterone treatment in older women: no strong effects on cognition. Neurobiol Aging (2004) 0.88
Estrogen use and early onset Alzheimer's disease: a population-based study. J Neurol Neurosurg Psychiatry (1999) 0.88
A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women: evidence for a limited window of opportunity. Neuropsychology (2010) 0.87
Clinically relevant hormone treatments fail to induce spinogenesis in prefrontal cortex of aged female rhesus monkeys. J Neurosci (2012) 0.86
Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory. Curr Med Res Opin (1976) 0.84
Burden of Alzheimer's disease-related mortality in the United States, 1999-2008. J Am Geriatr Soc (2012) 0.82
Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Psychoneuroendocrinology (2005) 0.81
Estrogen to treat Alzheimer's disease: too little, too late? So what's a woman to do? Neurology (2000) 0.81
Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci (1995) 0.79
Reply to 'Hormone in the hot seat'. Nat Med (2006) 0.77